A growing number of studies indicate a link between oxidative stress and cancer. We previously developed a rat model of renal cell carcinoma (RCC) induced by ferric nitrilotriacetate (Fe-NTA). Here, we performed a genome-wide analysis to study characteristics of genomic alteration and identify putative genes involved in the development of Fe-NTA-induced RCCs. Arraybased comparative genomic hybridization analyses revealed a chromosomal loss spanning chromosome 8 in most of the RCCs studied, with a common deletion at 8q31-32, which was confirmed by loss of heterozygosity (LOH) analysis. Studies of gene expression in RCCs or following Fe-NTA treatment revealed globally decreased transcription levels of 34 genes derived from chromosome 8 that are expressed in the kidney. Among them, the aminoacylase 1 (Acy1) gene, which maps to 8q32 and is highly expressed in the kidney, displayed a significantly decreased level of expression in RCCs. Significant amounts of the Acy1 protein were detected in the cytoplasm as well as in the nuclei of renal proximal tubular cells of untreated rats. Transfection of Acy1 into RCC cell lines inhibited proliferation and colony formation on soft agar. An increased number of apoptotic cells were observed following Acy1 transfection. The rat 8q31-32 chromosomal region corresponds to human 3p21.31-24.1, a hot spot where LOH is frequently found in various human cancers. Thus, Fe-NTA-induced renal tumor model is ideal for studying the link between deletions within this region and tumor formation. Our data demonstrate that Acy1 functions as a tumor suppressor in this rat RCC model.
Introduction
Living cells are constantly exposed to potentially damaging reactive oxygen and reactive nitrogen species. These reactive species are produced either by normal cellular metabolism or by exposure to various xenobiotics, including chlorinated compounds, transitional metal ions, radiation and barbiturates (1, 2) . A growing body of evidence has established a link between oxidative damage and cancer (3) (4) (5) (6) .
We have developed a rodent model of renal cell carcinoma (RCC) induced by ferric nitrilotriacetate (Fe-NTA, an iron chelate) in order to study the mechanisms of oxidative stress-induced cancer. Fe-NTA administration induces renal proximal tubular damage, a consequence of a Fenton-like reaction that ultimately leads to a high incidence (60-92%) of RCCs in rodents (7) (8) (9) . Previous studies revealed that oxidatively modified DNA bases including 8-oxoguanine and a major lipid peroxidation product, 4-hydroxy-2-nonenal, along with modified proteins, display increased levels during the early stages of RCC development in this rodent cancer model (10) (11) (12) (13) . The characteristic spectrum of DNA mutations detected following intraperitoneal administration of Fe-NTA include deletions with short homologous sequences at the deletion junctions as well as single-nucleotide substitutions at G:C sites (14) .
Genetic analysis of Fe-NTA-induced RCCs revealed frequent inactivation of the p15 INK4B and p16 INK4A (p16) tumor suppressor genes as a result of deletions, point mutations or methylation of the promoter region (15, 16) . Recently, Liu et al. (17) reported data demonstrating the activation of a novel b-catenin pathway that occurs as a consequence of amplification and overexpression of the ptprz1 tyrosine phosphatase in Fe-NTA-induced RCCs. Importantly, this was the first study demonstrating that chronic oxidative stress is a cause of genomic amplification. Alternatively, non-genetic alterations also play a role in Fe-NTA-induced carcinogenesis. Annexin 2 (Anx2) is under the control of the cellular redox status, and its persistent overexpression was found to be associated in a concentration-dependent fashion with proliferation and metastasis (18) . Thioredoxin binding protein-2, an antagonist of thioredoxin, is inactivated in practically all RCCs induced by Fe-NTA, due to methylation of its promoter region (19) . Notably, a recent epidemiological study showed surprisingly that iron reduction associated with phlebotomy in a supposedly normal population but with peripheral arterial disease was correlated with a significantly decreased cancer risk (20) . However, more studies are necessary to fully understand the mechanism of iron-induced tumor formation.
In the present study, we performed array-based comparative genomic hybridization (aCGH) and loss of heterozygosity (LOH) analyses to further evaluate chromosomal regions involved in Fe-NTA-induced RCC. By combining these data with complementary DNA (cDNA) microarray results, we found that a reduction in aminoacylase 1 (Acy1) gene expression plays a role in Fe-NTA-induced renal cancer.
Materials and methods
Rat RCC model Fe-NTA solutions were prepared as described previously (11) . F1 hybrid rat strains were produced from crosses between the Fischer 344 and Brown-Norway rat strains (Charles River Japan, Yokohama, Japan) and were used under specific pathogen-free conditions to produce Fe-NTA-induced RCCs, as described previously (9) . The animals were kept under close observation and euthanized 12-15 months after the completion of Fe-NTA administration, at which time they exhibited persistent weight loss and distress. Tumorous and non-tumorous renal tissues were collected and stored at À80°C. Twenty-two cases of RCCs, which included grades 1, 2 and 3 tumors (9), were used in the study. Details of the RCCs are summarized in supplementary Table 1 (available at Carcinogenesis Online). All data in the figures are derived from identical sample numbers of RCCs. For the acute and subacute experiments, male Wistar rats (5-to 6-week-old; Shizuoka Laboratory Animal Center, Shizuoka, Japan) were used. For the acute study, renal tissues were harvested after a single injection (15 mg iron/kg; 0, 24 or 48 h); for the subacute study, samples were collected after repeated injections (5-10 mg iron/kg; 1 or 3 weeks) as described previously (10) . This in vivo study was approved by the animal experiment committee of the Graduate School of Medicine, Kyoto University. All chemicals were of analytical quality.
Array-based comparative genomic hybridization
We performed aCGH with an Agilent 185K rat genome CGH microarray chip (Agilent Technologies, Santa Clara, CA) according to the protocol recommended by the supplier. We used 13 Fe-NTA-induced rat RCCs and two cell lines established from rat RCCs (18) . Normal kidney tissue was used as a reference. For each array, samples of interest were labeled with Cy-5, whereas normal kidney tissue was labeled with Cy-3. Results were analyzed with the CGH Analytics Software (Version 3.4).
LOH analysis
Genomic DNA was isolated from frozen tissues according to standard procedures. Primers for each microsatellite marker were selected according to the reference rat genome database (http://rgd.mcw.edu/genomescanner/) so that the predicted polymerase chain reaction (PCR) products would differ in size by at least 10 bp. PCR conditions were optimized by employing gradient PCR and carried out with a Dice PCR thermal cycler (TP600; Takara Bio, Shiga, Japan). DNA products were analyzed by agarose gel electrophoresis. Allelic loss was determined by comparing the PCR products obtained using normal F1 tissue genomic DNA with those corresponding to RCC genomic DNA isolated from F1 hybrid rats.
Gene expression microarray
Total RNA was isolated using Isogen reagent (Nippon Gene Co. Ltd, Tokyo, Japan) according to the manufacturer's recommended protocol. The kidney samples were grouped as follows (n 5 2 rats per group): untreated control (6-week-old males), 1 week Fe-NTA treatment, 3 weeks Fe-NTA treatment, Fe-NTA-induced RCCs without peritoneal invasion or metastases and Fe-NTA-induced RCCs with pulmonary metastases. The cDNA microarray experiments were performed with the Rat Genome 230 2.0 array (Affymetrix, Santa Clara, CA) as described previously (21) . Microarray data were analyzed by using GeneChip analysis software (Focus array; Affymetrix).
Plasmid constructs
Rat Acy1 (GenBank BC_078930; 64-1290) cDNA was amplified from kidney messenger RNA by reverse transcription (RT)-PCR; amplified fragments were cloned into the EcoRI-SalI site of the pIRES2-AcGFP1 expression vector (Clontech, Palo Alto, CA) yielding pIRES2-AcGFP1-Acy1. The primer pairs used were 5#-GATGAATTC(EcoRI)ATGACCACCAAGGGTCCTGAG-3# (sense) and 5#-GATGTCGAC(SalI)TCAGCTTTCACCAGGCAGAGC-3# (antisense).
Antibodies
The anti-aminoacylase/Acy1 (AF2900) polyclonal antibody was purchased from R&D Systems (Minneapolis, MN). The anti-sphingosine kinase type 1 (SphK1) polyclonal (ab46719) and anti-glyceraldehyde 3-phosphate dehydrogenease monoclonal (ab9484) antibodies were purchased from Abcam K.K. (Tokyo, Japan).
Western blot analysis
Tissue proteins were prepared by homogenizing in radio immunoprecipitation assay buffer (20 mM Tris, pH 7.4, 0.1% sodium dodecyl sulfate, 1% Triton X-100 and 1% sodium deoxycholate) supplemented with protease inhibitor cocktail tablets (Roche Diagnostics GmbH, Mannheim, Germany). Western blot analysis was performed as described previously (22) .
Histological analysis
Tissue samples were fixed in 10% phosphate-buffered formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin and observed under a light microscope. Immunohistochemical analysis employed the avidinbiotin complex method as described previously (23) .
Semiquantitative RT-PCR Semiquantitative RT-PCR was performed as described previously (24) . Primers for studying gene expression were Acy1 (GenBank accession number BC_078930; amplified product encompassing nt 673-948; 58°C annealing temperature, 32 cycles) and SphK1 (GenBank accession number NM_133386; amplified product encompassing nt 2490-2739; 60°C annealing temperature, 32 cycles). b-Actin (Genbank accession number NM_007393; amplified product encompassing nt 1061-1163; 58°C annealing temperature, 22 cycles) was used as an internal control.
Cell culture FRCC001 and FRCC562 cell lines were established from Fe-NTA-induced RCCs as described previously (18) . 786-0, a human RCC cell line (25) , was kindly provided by Dr T.Y. (Department of Urology, Graduate School of Medicine, Kyoto University). All cell lines were cultured at 37°C in a 5% CO 2 atmosphere in Dulbecco's modified Eagle's medium (GIBCO, Invitrogen Life Technologies, Carlsbad, CA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 lg/ml streptomycin and 2 mmol/l L-glutamine.
Cell proliferation assay
The FRCC001, FRCC562 and 786-0 cell lines were stably transfected with an Acy1-expressing vector using the Lipofectamine 2000 reagent (Invitrogen Life Technologies) according to the protocol recommended by the supplier. An empty vector was used as a negative control of transfection. Cell proliferation assays were performed by measuring cell viability with the Cell Counting Kit-8 (Dojindo Molecular Technologies, Gaithersburg, MD) according to the manufacturer's protocol. Absorbance of cell solutions was measured at 450 nm with a microplate reader. Each transfection experiment was carried out in triplicate.
Soft agar assay for colony formation
The FRCC001, FRCC562 and 786-0 cell lines were stably transfected with the Acy1-expressing vector as described above. An empty vector was used as a negative control of transfection. Soft agar colony formation assays were performed as described previously (26) . Briefly, 5000 cells in each group were plated into each well of a six-well plate that contained 0.5% agar and incubated at 37°C in a humidified incubator for 10-14 days. The cells were fed every 4 days with 2 ml of culture medium. Colonies were visualized by staining each well with 0.5 ml of 0.005% crystal violet (Sigma-Aldrich, St Louis, MO) for a minimum of 1 h and then counted with an inverted phase contrast microscope. Each assay was carried out in triplicate.
Cell apoptosis assay
The FRCC001, FRCC562 and 786-0 cell lines were stably transfected with the Acy1 expression vector as described above. An empty vector was used as a negative control of transfection. Apoptosis assays were performed using the In Situ Cell Death Detection Kit TMR red (Roche Diagnostics, Indianapolis, IN) according to the manufacturer's protocol. Detection and quantification of apoptotic cells were based on the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling method of labeling DNA strand breaks, and products were analyzed by fluorescence microscopy. Each experiment was performed in triplicate.
Statistical analysis
Statistical analyses were based on the Students's t-test, which was modified for unequal variances when necessary. A Mantel-Haenszel analysis was also performed. A P , 0.05 was considered statistically significant.
Results
Frequent monoallelic loss of chromosome 8 in the Fe-NTA-induced rat RCCs We analyzed 13 Fe-NTA-induced rat RCCs and two cell lines established from these tumors, coupled with aCGH analyses. Chromosome 8 revealed one of the highest incidences of common monoallelic loss among the 20 autosomes and X chromosome ( Figure 1A ). Detailed reports of the entire aCGH analyses will be published elsewhere (S.Akatsuka and S.Toyokuni, in preparation).
LOH on chromosome 8 reveals no allelic preference
To confirm the monoallelic loss of chromosome 8 and to evaluate whether there is any preference for either allele, LOH analyses were performed using 31 microsatellite markers spanning the major part of chromosome 8 ( Figure 1B and C). We analyzed 22 RCCs including grade 1, 2 and 3 tumors ( Figure 1B) . LOH was detected on large areas of chromosome 8, with a range of 18-79%, which was consistent with the results of the aCGH analyses. No preference for either allele was observed, as shown in Figure 1B . Certain regions, including 8q31 and 8q32, exhibited a relatively higher incidence of LOH, with an average frequency of 56.74% for the markers indicated in these regions ( Figure 1C ). The highest frequency observed was 78.9% at D8Mgh11, located at 8q32 ( Figure 1C ). We observed no significant association between the tumor grade and LOH frequency.
Gene expression microarray analysis of chromosome 8 shows low global expression levels in the Fe-NTA-induced RCCs Since LOH is generally associated with the inactivation of tumor suppressor genes, the observed high frequency of LOH on chromosome 8 provided an incentive to study alterations in the gene expression profile (Gene Expression Omnibus accession number GSE7625). To gain insights into the relationship between LOH status and gene expression, the global transcriptome (27) corresponding to chromosome 8 was first evaluated. The transcriptome was analyzed for each physical region (8q11-13, 8q21-24 and 8q31-32). The entire repertoire of messenger RNA transcripts on the microarray chip corresponding to each region was summed up for each group of samples Aminoacylase 1 as a tumor suppressor gene (supplementary Table 2 is available at Carcinogenesis Online). Decreased global transcription on chromosome 8 was observed in every Fe-NTA-treated sample and in three of four RCC samples. Among the nine physical regions on chromosome 8, the transcriptomes of 8q31 and 8q32 displayed significantly decreased expression in all the RCC samples as compared with the normal kidney tissue samples (supplementary Table 2 is available at Carcinogenesis Online). This is consistent with the data demonstrating that a high frequency of monoallelic deletion is observed on chromosome 8, particularly at the 8q31-32 region (Figure 1) . Therefore, we focused on the genes located within this chromosomal area.
Association of Acy1 with Fe-NTA-induced RCC The high incidence of LOH found on chromosome 8q31-32 in the Fe-NTA-induced RCC samples suggested that a putative tumor suppressor gene in this region may be involved in the development of RCCs. Thus, we evaluated the expression levels for individual genes present on the cDNA microarray chip. The expression of 34 genes that mapped to chromosome 8 was decreased incrementally in the kidney during the development of RCC (Table I) . Among this gene set, Acy1, which maps to 8q32 region, was highly expressed in normal kidney but displayed a significant decrease in gene expression during RCC progression.
To validate the microarray results, we evaluated Acy1 expression by employing semiquatitative RT-PCR, western blotting and immunohistochemical analyses. In the untreated normal condition, Acy1 was most prominently expressed in the liver and kidney, whereas its expression was low in the spleen, lung, heart and small intestine ( Figure  2A) . At the protein level, the highest levels were observed in kidney ( Figure 2B ). Acy1 was primarily localized to the cytosol, but was also detectable in the nuclear, microsomal and mitochondrial fractions ( Figure 2C ). Acy1 protein was significantly decreased in the kidney following treatment with Fe-NTA for 3 weeks ( Figure 3A ). Further downregulation of Acy1 protein was observed in the RCC samples ( Figure 3A and B) . Immunohistochemical analysis of RCC tissues supported these data, demonstrating an absence of Acy1 protein in the tumor cells ( Figure 3C ). These results suggested that loss of Acy1 protein was associated with Fe-NTA-induced RCC.
Acy1 inhibits proliferation and promotes apoptosis
To further study the role of the Acy1 gene, we performed experiments using cultured RCC cell lines of both rat and human origin. When these cells were transfected with the Acy1 expression vector, they grew slower than those cells transfected with an empty vector ( Figures  4A and B) . Similar results were obtained when the human RCC cell line 786-0 was used ( Figure 4C ). To further confirm these results, a soft agar colony formation assay was used. A significant decrease in the number of colonies was observed when tumor cells were transfected with exogenous Acy1 (Figure 5A and B) . In addition, the size of the colonies subjected to Acy1 transfection was smaller than those from cells transfected with empty vector ( Figure 5A ).
We also tested whether Acy1 inhibits cell growth by inducing apoptosis. We observed a significant percentage of apoptotic cells in the FRCC001, FRCC562 and 786-0 cell lines following Acy1 transfection, as judged by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling analysis ( Figure 5C and D) .
Interaction of Acy1 and Sphk1
SphK1 is a putative binding partner of Acy1 (28) . We found that most of the RCCs displayed an increased expression at the messenger RNA and protein levels for SphK1, but not SphK2, as compared with the corresponding levels in normal kidney (supplementary Figure 1A and B is available at Carcinogenesis Online). In addition, a SphK1-Acy1 complex was detected in a subset of the RCC cell lines (supplementary Figure 1C is available at Carcinogenesis Online).
Discussion
The Fe-NTA-induced RCC model established previously (29) offers a superb opportunity to elucidate the molecular mechanisms of ironmediated oxidative stress-induced RCC (6) . In the present study, we performed aCGH analyses using 13 RCC tumor samples and two cell lines established from rat RCCs. We found that rat chromosome 8, particularly 8q31-32, is a hot spot for monoallelic deletion (Figure 1 ). This chromosomal region is syntenic to human 3p21.31-24.1. Genetic studies on several human cancers have shown that the 3p13-3p23 region is commonly deleted in the carcinomas of the lung, kidney and uterine cervix (30) (31) (32) (33) . Thus, Fe-NTA-induced RCC represents an ideal model to study the etiology of these chromosomal deletions.
Chromosomal aberrations apparently ensue as a result of DNA damage and DNA-protein cross-links. It is well established that a variety of oxidative insults to DNA are generated early in the tumorigenic process, including 8-hydroxy-2#-deoxyguanosine (10) and thymine-tyrosine cross-link (34) . In order to describe common features relating to the distribution of oxidation-induced DNA damage in the genome, we developed a novel method based on immunoprecipitation to map the oxidation-dependent damage in the genome. We observed two major oxidation-related DNA base modifications in our mice experiments, 8-hydroxy-2#-deoxyguanosine and acrolein-dA, which are not randomly distributed, but rather are associated with specific chromosomal regions (35) . We then performed transcriptome analysis and found a widespread reduction in transcriptional activity within this chromosome (supplementary Table 2 is available at Carcinogenesis Online). There was an exception to this transcriptional repression (RCC for case #1), but we believe that alteration of chromosomal positioning within the nuclei (i.e. chromosome territory) (36) during tumorigenesis may explain this discrepancy. Locally, in addition to the 8q31-32 region, we also observed an obviously decreased expression in the 8q12 region, where no prominent chromosomal loss was observed with aCGH and LOH analyses (Figure 1 and data not shown). This may be associated with the fact that 8q12 showed a lower basal transcriptional level.
In the current study, we focused on Acy1 (EC 3.5.1.14), which maps to the 8q32 chromosome region in rats, as a candidate tumor suppressor gene (Table 1) . Decreased expression of Acy1 in carcinoma cells was reported previously (30, 37) , but the molecular mechanisms were not investigated. N-terminal acylation of proteins is a widespread and highly conserved process that serves to stabilize proteins (38) . Although the biosynthetic pathways that mediate amino acid acetylation have been studied extensively, less attention has been paid to the catabolism of N-acetylated peptides. N-acetylated amino acids can be released by an N-acyl-peptide hydrolase from peptides that are generated by proteolytic degradation. Acy1 is a cytosolic, homodimeric, zinc-binding enzyme that catalyzes the hydrolysis of acylated L-amino acids to L-amino acids and an acyl group (39, 40) . Recently, Acy1 deficiency has been recognized in children as a novel inborn error of metabolism (online mendelian inheritance in man number 609924) in which inactivation of Acy1 results in increased urinary excretion of several N-acetylamino acids, and in most cases, this genetic defect leads to impaired psychomotor development (41, 42) . Also, it was reported that the N-acetylamino acids, N-acetyllysine and Nacetylmethionine can be transported into LLC-PK1 porcine renal tubular cells and be used to assist the growth of these cells (43) .
Acy1 expression was found to be ubiquitous, with the highest level observed in the kidney (Figure 2) . However, the level of expression was significantly decreased in the kidney following Fe-NTA treatment and further decreased in the Fe-NTA-induced RCCs (Figure 3 and Table I ), suggesting that Acy1 is associated with Fe-NTA-induced tumor formation. In terms of the mechanisms underlying this phenomenon, homozygous deletion of the Acy1 gene was not observed, as judged by aCGH analysis (data not shown). Thus, it seems probably that either methylation of the promoter region or modulation of gene expression by microRNAs is a possible explanation and should be (Figures 4 and 5) . Thus, we conclude that Acy1 plays a tumor suppressor role in the development of Fe-NTA-induced RCCs. Although Acy1 has been studied intensively in the context of salvaging N-acetylated amino acids during intracellular protein catabolism, the pathophysiological mechanisms involving Acy1 remain unclear. Fe-NTA causes oxidative renal proximal tubular damage (44) . No repair followed by proliferation of tubular cells leads to uremia and death. In such a situation, emergent mechanisms probably work to promote tubular proliferation, sacrificing certain error-safe mechanism. This may cause a transition from non-neoplastic to neoplastic cells. One hypothesis is that cancer cells streamline processes for stabilizing proteins and recycling acylated amino acids, in order to maintain rapid protein metabolism and a concomitant high rate of proliferation.
We also point out that SphK1 and its product sphingosine-1-phosphate promote cell growth and inhibit apoptosis of tumor cells (45, 46) . Previous reports have suggested an interaction between SphK1 and Acy1 (28) , but the data are controversial, most probably due to differences in the experimental conditions. In NIH3T3 fibroblasts, transfection of full-length Acy1 enhanced the growth-promoting and anti-apoptotic effects of SphK1 by virtue of its interaction with Sphk1, leading to a redistribution of Sphk1. However, a C-terminal fragment of Acy1, which also interacts with Sphk1, reduced the ability of Sphk1 to stimulate cell growth and block apoptosis. These results suggest that Kd, kidney; Lv, liver; Sp, spleen; Crb, cerebrum; Cbl, cerebellum; Pc, pancreas; Lg, lung; Tst, testis; Ht, heart; SInt, small intestine; GAPDH, glyceraldehyde 3-phosphate dehydrogenease. (C) Western blotting to detect the subcellular distribution of Acy1 in control rat kidney samples. Total, total lysate; Nucl, nuclear fraction; Micr, microsomal fraction; Mito, mitochondrial fraction; Cytosol, cytosolic fraction. other proteins are also required for mediating the effects of the SphK1-Acy1 complex on apoptosis and proliferation, by promoting the redistribution of SphK1 (28) . We evaluated the expression of SphK1 in Fe-NTA-induced RCCs and found that most of the RCCs displayed an elevated SphK1 expression as compared with normal kidney. In addition, the SphK1-Acy1 complex was detected in the RCC cell lines (supplementary Figure 1 is available at Carcinogenesis Online). Thus, one function of Acy1 in Fe-NTA-induced RCC may be activation of SphK1. However, there may be other explanations, particularly since Acy1 is found in the nucleus of normal proximal tubular cells ( Figures  2C and 3C ). It is possible that certain as yet unidentified nuclear proteins are substrates for Acy1, and this hypothesis is currently being investigated.
In conclusion, we have demonstrated that the Acy1 gene possesses a tumor suppressor function in Fe-NTA-induced RCC. The molecular mechanism that defines this role of Acy1 in RCCs remains to be elucidated. Fe-NTA-induced RCC represents an ideal in vivo model to study how certain chromosomal hot spots syntenic to human 3p are susceptible to genomic deletions. The importance of this iron-induced tumor model is emphasized by a recent study that unexpectedly found that iron reduction associated with phlebotomy in a supposedly normal population was correlated with a significantly decreased risk for developing cancer (20) .
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